Navigation Links
Better Drug for Heart Transplant

A new study shows the drug everolimus is better at reducing problems in heart transplant patients than one of the currently used drugs. Specifically the drug reduced the incidence of a serious disorder that can cause deterioration of the graft known as coronary vasculopathy.//

Previous studies have shown everolimus combined with another drug reduced the rejection and risk of infection in kidney transplant patients. Researchers from Temple University in Philadelphia conducted a study to determine if everolimus is also effective for heart transplant patients.

For the study, 634 patients were randomly assigned to receive one of two doses of everolimus or another drug, azathioprine, after having a heart transplant. The drugs were given once a day in combination with other standard treatments. Researchers followed patients for one year to determine if they had any complications from the transplant.

Researchers report the patients on either dose of everolimus fared much better than the patients on azathioprine. After one year, researchers say it was clear everolimus was significantly more effective than azathioprine in preventing vasculopathy. Study authors write, "Everolimus combined with cyclosporine and corticosteroids during the first 12 months is a safe and effective immunosuppressant regimen for use in recipients of a first heart transplant."

Researchers say further evaluation and follow-up are needed to determine the optimal dose. However, they say the findings of this study offer some optimism that everolimus is a promising agent for the management of rejection and vasculopathy after heart transplantation.
'"/>




Page: 1

Related medicine news :

1. Better prostate cancer detection
2. Better Treatment for obesity
3. For a Better Memory
4. Baby Talk Better Than Adult Speech
5. Drug Combo Works Better for children with ADHD, Tics
6. Better skin with lasers
7. Better diabetes treatment promises Vanadium
8. Better Prostate Cancer Test
9. Better Diet Even Late in Life May Prolong It
10. Better Care Required for Breast Cancer Survivors
11. Two drugs Mays Be Better Than One For Prostate Enlargement
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:4/2/2020)... ... 02, 2020 , ... Since the onset of the COVID-19 pandemic, there hasn’t ... ( https://www.goparrot.ai/ ) founder Yaniv Nissim has stepped up to the plate to ... safety, has created new standards for delivering food during this time of COVID-19 so ...
(Date:4/1/2020)... ... ... According to data released by Power to Decide , an estimated 193,110 ... in counties impacted by the implementation of the Title X Family Planning Program “domestic ... Title X resources. , The domestic gag rule requires health providers receiving ...
(Date:4/1/2020)... (PRWEB) , ... April 01, 2020 , ... ... and private of information under California law,” says Keller Grover LLP attorney Eric ... timely notice of data breaches and the negligent release and disclosure of medical ...
(Date:3/28/2020)... ... March 27, 2020 , ... With social distancing, or more ... the day, people of all ages are challenged to find different ways to ... in the best of times—the physical distance mandated to prevent the pandemic’s spread ...
(Date:3/28/2020)... (PRWEB) , ... March 28, 2020 , ... ... cycle management services, integrated practice management, and patient engagement solutions has expanded the ... outbreak. , In this time of crisis, telemedicine has a big role ...
Breaking Medicine News(10 mins):
(Date:4/7/2020)... ... 07, 2020 , ... During a pandemic, other human health ... availability, patients suffering from many different medical ailments will be forced to take ... That is why it is so essential to maintain a robust telemedicine capability ...
(Date:4/5/2020)... ... , ... In a time of strife, baby brand SwaddleDesigns ... facemasks. , On March 18th when SwaddleDesigns (located in Seattle, WA) learned the ... no medical-grade facemasks were available, SwaddleDesigns founder& CEO, Lynette Damir R.N. knew her ...
(Date:4/5/2020)... ... April 05, 2020 , ... INTRODUCTION , ... aetiology and pathology of COVID-19[1], we are committed to the non-profit dissemination of ... , The SARS-CoV-2-mediated post-entry suppression of ACE2 mRNA expression in host cells is ...
Breaking Medicine Technology: